These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 20104

  • 1. Effects of asparagine synthetase inhibitors on asparaginase resistant tumors.
    Uren JR, Chang PK, Handschumacher RE.
    Biochem Pharmacol; 1977 Aug 01; 26(15):1405-10. PubMed ID: 20104
    [No Abstract] [Full Text] [Related]

  • 2. Ethacrynic acid--an inhibitor of L-asparagine synthetase.
    Jayaram HN, Cooney DA, Milman HA, Homan ER, King WM, Cragoe EJ.
    Biochem Pharmacol; 1975 Oct 01; 24(19):1787-92. PubMed ID: 9943
    [No Abstract] [Full Text] [Related]

  • 3. Inhibitors of L-asparagine synthetase, in vitro.
    Cooney DA, Driscoll JS, Milman HA, Jayaram HN, Davis RD.
    Cancer Treat Rep; 1976 Oct 01; 60(10):1493-557. PubMed ID: 14784
    [Abstract] [Full Text] [Related]

  • 4. Don, conv and donv--I. Inhibition of L-asparagine synthetase in vitro.
    Jayaram HN, Cooney DA, Milman HA, Homan ER, Rosenbluth RJ.
    Biochem Pharmacol; 1976 Jul 15; 25(14):1571-82. PubMed ID: 8046
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of L-asparagine synthetase by mineral cations.
    Milman HA, Cooney DA, Ward JM.
    Toxicol Appl Pharmacol; 1979 Sep 30; 50(3):573-80. PubMed ID: 42170
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacology of L-asparaginase and the effects of host and enzyme modification.
    Uren JR.
    Cancer Treat Rep; 1981 Sep 30; 65 Suppl 4():47-55. PubMed ID: 6125260
    [Abstract] [Full Text] [Related]

  • 7. L-Asparagine synthetase in serum as a marker for neoplasia.
    Cooney DA, King VD, Cable RG, Taylor B, Wodinsky I.
    Cancer Res; 1976 Sep 30; 36(9 pt.1):3238-45. PubMed ID: 10081
    [Abstract] [Full Text] [Related]

  • 8. The downregulation of asparagine synthetase expression can increase the sensitivity of cells resistant to l-asparaginase.
    Li BS, Gu LJ, Luo CY, Li WS, Jiang LM, Shen SH, Jiang H, Shen SH, Zhang B, Chen J, Xue HL, Tang JY.
    Leukemia; 2006 Dec 30; 20(12):2199-201. PubMed ID: 17039232
    [No Abstract] [Full Text] [Related]

  • 9. Potential inhibitors of L-asparagine biosynthesis. 4. Substituted sulfonamide and sulfonylhydrazide analogues of L-asparagine.
    Brynes S, Burckart GJ, Mokotoff M.
    J Med Chem; 1978 Jan 30; 21(1):45-9. PubMed ID: 22754
    [Abstract] [Full Text] [Related]

  • 10. Regulators of the metabolism of L-asparagine: a search for endogenous inhibitors.
    Cooney DA, Jones MT, Milman HA, Young DM, Jayaram HN.
    Int J Biochem; 1980 Jan 30; 11(6):519-39. PubMed ID: 6103827
    [No Abstract] [Full Text] [Related]

  • 11. A radiometric method for the measurement of L-asparagine synthetase activity: comparison with available methods.
    Milman HA, Cooney DA, Applebee S.
    Int J Biochem; 1978 Jan 30; 9(11):803-16. PubMed ID: 33075
    [No Abstract] [Full Text] [Related]

  • 12. Potential antitumor agents via inhibitors of L-asparagine synthetase: substituted sulfonamides and sulfonyl hydrazides related to glutamine.
    Brynes S, Fiorina VJ, Cooney DA, Milman HA.
    J Pharm Sci; 1978 Nov 30; 67(11):1550-3. PubMed ID: 30838
    [Abstract] [Full Text] [Related]

  • 13. Biochemical characterization of U937 cells resistant to L-asparaginase: the role of asparagine synthetase.
    Kiriyama Y, Kubota M, Takimoto T, Kitoh T, Tanizawa A, Akiyama Y, Mikawa H.
    Leukemia; 1989 Apr 30; 3(4):294-7. PubMed ID: 2564453
    [Abstract] [Full Text] [Related]

  • 14. A comparative study of the antitumor effectiveness of E. coli and Erwinia asparaginases.
    Roberts J, Schmid FA, Old LJ, Stockert E.
    Cancer Biochem Biophys; 1976 May 30; 1(4):175-8. PubMed ID: 788892
    [Abstract] [Full Text] [Related]

  • 15. [Results of an experimental study of the antitumor activity of 1-asparaginase from E. coli and Erw. carotovora].
    Terent'eva TG, Sokolov AB, Navashin SM.
    Antibiotiki; 1977 Jan 30; 22(1):78-81. PubMed ID: 320935
    [Abstract] [Full Text] [Related]

  • 16. L-Asparagine synthetase: a marker for metastases.
    Cable RG, King VD, Cooney DA.
    Biochem Med; 1977 Feb 30; 17(1):54-66. PubMed ID: 14632
    [No Abstract] [Full Text] [Related]

  • 17. Asparaginyl-tRNA and resistance of murine leukaemias to L-asparaginase.
    Gallo RC, Longmore JL, Adamson RH.
    Nature; 1970 Sep 12; 227(5263):1134-6. PubMed ID: 5451107
    [No Abstract] [Full Text] [Related]

  • 18. L-asparaginyl-tRNA synthetase and L-asparagine synthetase activities of L-asparaginase-sensitive and -resistant forms of the mouse Gardner lymphoma 6C3HED.
    Davies MR, Lambert LP, Marshall RD.
    Clin Sci (Lond); 1979 Jan 12; 56(6):539-45. PubMed ID: 38936
    [Abstract] [Full Text] [Related]

  • 19. Glutaminase Activity of L-Asparaginase Contributes to Durable Preclinical Activity against Acute Lymphoblastic Leukemia.
    Chan WK, Horvath TD, Tan L, Link T, Harutyunyan KG, Pontikos MA, Anishkin A, Du D, Martin LA, Yin E, Rempe SB, Sukharev S, Konopleva M, Weinstein JN, Lorenzi PL.
    Mol Cancer Ther; 2019 Sep 12; 18(9):1587-1592. PubMed ID: 31209181
    [Abstract] [Full Text] [Related]

  • 20. Some properties of L-asparagine synthetase of the L-asparaginase-resistant mouse lymphoma 6C3HED [proceedings].
    Davies MR, Marshall RD.
    Biochem Soc Trans; 1979 Feb 12; 7(1):174-6. PubMed ID: 35419
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.